Continuing Education Credits 

Accreditation Statement

AXIS joint logo In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and the Wisconsin Hospital Association. AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. 
  
 IPCE LogoThis activity was planned by and for the health care team, and learners will receive 6.25 Interprofessional Continuing Education ICPE) credit for learning and change.
  

Credit Designation for Physicians
AXIS Medical Education designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.


Credit Designation for Nursing
AXIS Medical Education designates this continuing nursing education activity for 6.25 contact hours. Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Long Term Care Administration
This program has been submitted (but not yet approved) for Continuing Education for 12.25 total clock hours from NAB/NCERS.

AXIS Contact Information
For information about the accreditation of this program, please contact AXIS at 954-281-7524 or info@axismeded.org.

Disclosure of Conflicts of Interest
AXIS Medical Education requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Name of Faculty or Presenter

Reported Financial Relationship

Eric Borgerding

Nothing to disclose

Richard Brynteson

Nothing to disclose

Amy Dee

Nothing to disclose

Ron Galloway

Nothing to disclose

Jon Hoelter

Nothing to disclose

Pam Knecht

Nothing to disclose

Jane McLeod

Nothing to disclose

Todd Nova

Nothing to disclose

Michelle Rathman

Nothing to disclose

Jill Renken

Nothing to disclose

Josie Rudolphi

Nothing to disclose

Tim Size

Nothing to disclose

Dave Snow

Nothing to disclose

 

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity

Name of Planner/Manager

Reported Financial Relationship

Luke Beirl

Nothing to disclose

Cynthia Chicker

Nothing to disclose

Dan DeGroot

Nothing to disclose

Dean Eide

Nothing to disclose

John Eich

Nothing to disclose

Jennifer Frank

Nothing to disclose

Mike Gutsch

Nothing to disclose

David Hartberg

Nothing to disclose

Gordy Lewis

Nothing to disclose

Jeremy Levin

Nothing to disclose

Teresa Lindfors

Nothing to disclose

Kathryn Miller

Nothing to disclose

Brian Potter

Nothing to disclose

John Russell

Nothing to disclose

Carl Selvick

Nothing to disclose

Tim Size

Nothing to disclose

Brian Stephens

Nothing to disclose

DeAnn Thurmer

Nothing to disclose

Brian Vamstad

Nothing to disclose

Dee Morgillo, MEd, CHCP

Nothing to disclose

Robert Mocharuck, MD

Common Stock: Merck

Holly M. Hampe, D.Sc., RN, MHA, MRM

Nothing to disclose

 


Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Requirements for credit:   

  • Attend/participate in the educational activity and review all course materials. 
  • Complete the CE Declaration form online by 11:59 pm ET on July 14, 2019. Instructions will be provided. If you do not enter the online portal by the above date, you will not be able to retrieve your statement of participation.
  • Upon successful completion of the online form, your statement of completion will be presented to you to print. For NAB, you will enter your NABVerify number (R1234567) and your record will be loaded to NABVerify. 

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!
MSN MSN
Top